Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis have?
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis has 297 citations in the OpenAlex counts ScholarIQ stores.
When was Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis published?
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis has 2014 year in the ScholarIQ index.
What is the open-access status of Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis?
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis has closed oa status in the ScholarIQ index.
What is the DOI of Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis?
The DOI for Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis is on the source record.
What is the PMID of Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis?
The PMID for Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis is on the source record.
What is the OpenAlex record for Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis?
The OpenAlex for Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis is on the source record.